C. trachomatis Antibody (BDI168): sc-57670

C. trachomatis Antibody (BDI168) is a mouse monoclonal IgG1 antibody that detects Chlamydia trachomatis by immunofluorescence (IF). C. trachomatis is a significant intracellular pathogen responsible for various diseases, including sexually transmitted infections and trachoma, which can lead to blindness. The major outer membrane protein (MOMP) of C. trachomatis plays a crucial role in the bacterium′s ability to adhere to and invade host cells, making MOMP essential for the pathogenesis of infections. MOMP is characterized by unique structure, including multiple transmembrane domains that facilitate function as a porin, allowing passage of nutrients and waste products across bacterial membrane. Understanding MOMP structure is vital, as MOMP aids in developing diagnostic tools and serves as a potential target for vaccine development. C. trachomatis (BDI168) monoclonal antibody is specifically designed to recognize epitopes within the VS4 region of MOMP, ensuring accurate detection of the pathogen in infected tissues. This specificity is particularly important for differentiating between various serotypes of C. trachomatis, which can have different clinical implications. By utilizing C. trachomatis (BDI168) antibody in immunofluorescence (IF) applications, researchers can gain valuable insights into infection dynamics and pathophysiology of C. trachomatis, ultimately contributing to better diagnostic and therapeutic strategies.